Notice of Amendment-Public Meeting of the AHRQ National Advisory Council for Healthcare Research and Quality Subcommittee On Quality Measures for Children's Healthcare in Medicaid and Children's Health Insurance Programs, 46610 [E9-21690]

Download as PDF 46610 Federal Register / Vol. 74, No. 174 / Thursday, September 10, 2009 / Notices notify interested persons regarding their request to speak by October 8, 2009. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact AnnMarie Williams, Conference Management Staff, 301–796–5966, at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/ AdvisoryCommittees/ AboutAdvisoryCommittees/ ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: September 4, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–21810 Filed 9–9–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality erowe on DSK5CLS3C1PROD with NOTICES Notice of Amendment—Public Meeting of the AHRQ National Advisory Council for Healthcare Research and Quality Subcommittee On Quality Measures for Children’s Healthcare in Medicaid and Children’s Health Insurance Programs With this correction notice, the Agency for Healthcare Research and Quality (AHRQ) informs public of an Amendment made to the notice subject mentioned above which was published on August 20, 2009, Vol. 74, No. 160, pages 42079–42080, The amendment is to add at the end of section SUPPLEMENTARY INFORMATION, the following: ‘‘As previously noted, the meeting is open to the public and can also be joined via Webcast. The link to online registration for Webcast is https://www.ConnectLive.com/events/ AHRQ2009.’’ VerDate Nov<24>2008 15:13 Sep 09, 2009 Jkt 217001 Dated: September 3, 2009. Carolyn M. Clancy, Director. [FR Doc. E9–21690 Filed 9–9–09; 8:45 am] BILLING CODE 4160–90–M Dated: September 1, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–21920 Filed 9–9–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the following Subcommittee meeting: Time and Date: 10:30 a.m.–12:30 p.m., September 24, 2009. Place: The teleconference call will originate at the Centers for Disease Control and Prevention in Atlanta, Georgia. Please see ‘‘Supplementary Information’’ for details on accessing the teleconference. Status: Open to the public, teleconference access limited only by availability of telephone ports. The public is welcome to participate during the public comment period which is tentatively scheduled from 12:15 p.m.–12:25 p.m. Purpose: The Ethics Subcommittee will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners. Matters To Be Discussed: The teleconference agenda will include ethical guidance for ventilator distribution during a pandemic, update on CDC’s public health ethics activities, and follow-up on outstanding activities/reports. Agenda items are subject to change as priorities dictate. Supplementary Information: This conference call is scheduled to begin at 10:30 a.m. To participate in the teleconference, please dial 1/866/919– 3560 and enter conference code 4168828. You will then be automatically entered into the call. Contact Person for More Information: Drue Barrett, PhD, Designated Federal Officer, Ethics Subcommittee, CDC, 1600 Clifton Road, NE., M/S D–50, Atlanta, Georgia 30333. Telephone (404/639–4690. E-mail: dbarrett@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Clinical Resources. Date: September 28, 2009. Time: 10 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Wendy F. Davidson, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301– 402–8399, davidsonw@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: September 1, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–21791 Filed 9–9–09; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\10SEN1.SGM 10SEN1

Agencies

[Federal Register Volume 74, Number 174 (Thursday, September 10, 2009)]
[Notices]
[Page 46610]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-21690]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Amendment--Public Meeting of the AHRQ National Advisory 
Council for Healthcare Research and Quality Subcommittee On Quality 
Measures for Children's Healthcare in Medicaid and Children's Health 
Insurance Programs

    With this correction notice, the Agency for Healthcare Research and 
Quality (AHRQ) informs public of an Amendment made to the notice 
subject mentioned above which was published on August 20, 2009, Vol. 
74, No. 160, pages 42079-42080, The amendment is to add at the end of 
section SUPPLEMENTARY INFORMATION, the following: ``As previously 
noted, the meeting is open to the public and can also be joined via 
Webcast. The link to online registration for Webcast is https://
www.ConnectLive.com/events/AHRQ2009.''

    Dated: September 3, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9-21690 Filed 9-9-09; 8:45 am]
BILLING CODE 4160-90-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.